The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 03, 2014
Filed:
Apr. 05, 2007
Mark Ledeboer, Acton, MA (US);
David Messersmith, Somerville, MA (US);
Francois Maltais, Tewksbury, MA (US);
Huai Gao, Lincoln, MA (US);
Tiansheng Wang, Concord, MA (US);
Jingrong Cao, Newton, MA (US);
John Duffy, Northborough, MA (US);
Gabriel Martinez-botella, Wayland, MA (US);
Cornelia Forster, Pelham, NH (US);
Marion Wannamaker, Bolton, MA (US);
Francesco Salituro, Marlboro, MA (US);
Albert Pierce, Cambridge, MA (US);
Luc Farmer, Foxboro, MA (US);
Valerie Marone, Cambridge, MA (US);
Mark Ledeboer, Acton, MA (US);
David Messersmith, Somerville, MA (US);
Francois Maltais, Tewksbury, MA (US);
Huai Gao, Lincoln, MA (US);
Tiansheng Wang, Concord, MA (US);
Jingrong Cao, Newton, MA (US);
John Duffy, Northborough, MA (US);
Gabriel Martinez-Botella, Wayland, MA (US);
Cornelia Forster, Pelham, NH (US);
Marion Wannamaker, Bolton, MA (US);
Francesco Salituro, Marlboro, MA (US);
Albert Pierce, Cambridge, MA (US);
Luc Farmer, Foxboro, MA (US);
Valerie Marone, Cambridge, MA (US);
Vertex Pharmaceuticals Incorporated, Boston, MA (US);
Abstract
The present invention relates to compounds useful as inhibitors of protein kinases, particularly of JAK family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The compounds are generally represented by structural formula I or pharmaceutically acceptable salts thereof: